Zylem Biosciences Inc

Zylem Biosciences Inc, based in Chicago, IL, is dedicated to extending healthy human lifespan through the development of therapeutics targeting cancer, ocular, and cardiovascular diseases, along with anti-aging treatments focused on mitochondrial restoration. The company's innovative approach relies on its proprietary metabolic redox modulators (MRMs), which serve as tunable mimics of natural molecules that effectively modulate oxidative stress and inflammation—key contributors to disease and aging.

The firm's pipeline is primarily concentrated on targeted oncology, where MRMs aim to induce a "Metabolic Checkmate" by addressing three hallmarks of cancer simultaneously: enhancing immune destruction, reducing tumor-promoting inflammation, and promoting cancer cell death through increased oxidative stress. This pioneering work positions Zylem as a significant player in the biotechnology field, tackling previously undruggable targets to offer new avenues for treatment.

Generated from the website